Patent details

EP2797622 Title: PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

Basic Information

Publication number:
EP2797622
PCT Application Number:
PCT/US/2012/072182
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP128166246
PCT Publication Number:
WO/2013/102144
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
French Title of Invention:
VARIANTES DES PH20 POLYPEPTIDES, COMPOSITIONS ET LEURS UTILISATIONS
German Title of Invention:
PH20 POLYPEPTIDVARIANTEN, FORMULIERUNGEN UND DEREN VERWENDUNG
SPC Number:

Dates

Filing date:
28/12/2012
Grant date:
12/10/2016
EP Publication Date:
12/10/2016
PCT Publication Date:
04/07/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/11/2014
EP B1 Publication Date:
12/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/12/2016
Expiration date:
28/12/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/12/2012
 
 

Name:
Halozyme Inc.
Address:
11388 Sorrento Valley Road, San Diego, CA 92121, United States (US)

Inventor

1

Name:
CONNOR Robert, James
Address:
United States (US)

2

Name:
ZHAO Qiping
Address:
United States (US)

3

Name:
WEI Ge
Address:
United States (US)

4

Name:
SHEPARD H., Michael
Address:
United States (US)

Priority

1

Priority Number:
201161631313
Priority Date:
30/12/2011
Priority Country:
United States (US)

2

Priority Number:
201261796208
Priority Date:
01/11/2012
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/47;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages